Healthcare & Life Sciences
Aurion Biotech
United Statesaurionbiotech.com/
Aurion Biotech is a series b startup based in United States. 1 investor tracked.
Activeseries-b
series-b
Stage
2018
Founded
1
Investors
About Aurion Biotech
Aurion Biotech is a company founded in 2018 headquartered in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Aurion Biotech is a clinical-stage biotechnology company developing a cell therapy for the treatment of corneal edema secondary to endothelial dysfunction. The company's treatment aims to regenerate healthy cells in the cornea, potentially restoring vision for millions of patients.
Explore Aurion Biotech's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.